Cargando…
Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy
AIMS/HYPOTHESIS: Hyper-reflective crystalline deposits found in retinal lesions have been suggested to predict the progression of diabetic retinopathy, but the nature of these structures remains unknown. METHODS: Scanning electron microscopy and immunohistochemistry were used to identify cholesterol...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390399/ https://www.ncbi.nlm.nih.gov/pubmed/37311879 http://dx.doi.org/10.1007/s00125-023-05949-w |
_version_ | 1785082469405425664 |
---|---|
author | Hammer, Sandra S. Dorweiler, Tim F. McFarland, Delaney Adu-Agyeiwaah, Yvonne Mast, Natalia El-Darzi, Nicole Fortmann, Seth D. Nooti, Sunil Agrawal, Devendra K. Pikuleva, Irina A. Abela, George S. Grant, Maria B. Busik, Julia V. |
author_facet | Hammer, Sandra S. Dorweiler, Tim F. McFarland, Delaney Adu-Agyeiwaah, Yvonne Mast, Natalia El-Darzi, Nicole Fortmann, Seth D. Nooti, Sunil Agrawal, Devendra K. Pikuleva, Irina A. Abela, George S. Grant, Maria B. Busik, Julia V. |
author_sort | Hammer, Sandra S. |
collection | PubMed |
description | AIMS/HYPOTHESIS: Hyper-reflective crystalline deposits found in retinal lesions have been suggested to predict the progression of diabetic retinopathy, but the nature of these structures remains unknown. METHODS: Scanning electron microscopy and immunohistochemistry were used to identify cholesterol crystals (CCs) in human donor, pig and mouse tissue. The effects of CCs were analysed in bovine retinal endothelial cells in vitro and in db/db mice in vivo using quantitative RT-PCR, bulk RNA sequencing, and cell death and permeability assays. Cholesterol homeostasis was determined using (2)H(2)O and (2)H(7)-cholesterol. RESULTS: We identified hyper-reflective crystalline deposits in human diabetic retina as CCs. Similarly, CCs were found in the retina of a diabetic mouse model and a high-cholesterol diet-fed pig model. Cell culture studies demonstrated that treatment of retinal cells with CCs can recapitulate all major pathogenic mechanisms leading to diabetic retinopathy, including inflammation, cell death and breakdown of the blood–retinal barrier. Fibrates, statins and α-cyclodextrin effectively dissolved CCs present in in vitro models of diabetic retinopathy, and prevented CC-induced endothelial pathology. Treatment of a diabetic mouse model with α-cyclodextrin reduced cholesterol levels and CC formation in the retina, and prevented diabetic retinopathy. CONCLUSIONS/INTERPRETATION: We established that cholesterol accumulation and CC formation are a unifying pathogenic mechanism in the development of diabetic retinopathy. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-023-05949-w) contains peer-reviewed but unedited supplementary material. |
format | Online Article Text |
id | pubmed-10390399 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-103903992023-08-02 Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy Hammer, Sandra S. Dorweiler, Tim F. McFarland, Delaney Adu-Agyeiwaah, Yvonne Mast, Natalia El-Darzi, Nicole Fortmann, Seth D. Nooti, Sunil Agrawal, Devendra K. Pikuleva, Irina A. Abela, George S. Grant, Maria B. Busik, Julia V. Diabetologia Article AIMS/HYPOTHESIS: Hyper-reflective crystalline deposits found in retinal lesions have been suggested to predict the progression of diabetic retinopathy, but the nature of these structures remains unknown. METHODS: Scanning electron microscopy and immunohistochemistry were used to identify cholesterol crystals (CCs) in human donor, pig and mouse tissue. The effects of CCs were analysed in bovine retinal endothelial cells in vitro and in db/db mice in vivo using quantitative RT-PCR, bulk RNA sequencing, and cell death and permeability assays. Cholesterol homeostasis was determined using (2)H(2)O and (2)H(7)-cholesterol. RESULTS: We identified hyper-reflective crystalline deposits in human diabetic retina as CCs. Similarly, CCs were found in the retina of a diabetic mouse model and a high-cholesterol diet-fed pig model. Cell culture studies demonstrated that treatment of retinal cells with CCs can recapitulate all major pathogenic mechanisms leading to diabetic retinopathy, including inflammation, cell death and breakdown of the blood–retinal barrier. Fibrates, statins and α-cyclodextrin effectively dissolved CCs present in in vitro models of diabetic retinopathy, and prevented CC-induced endothelial pathology. Treatment of a diabetic mouse model with α-cyclodextrin reduced cholesterol levels and CC formation in the retina, and prevented diabetic retinopathy. CONCLUSIONS/INTERPRETATION: We established that cholesterol accumulation and CC formation are a unifying pathogenic mechanism in the development of diabetic retinopathy. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-023-05949-w) contains peer-reviewed but unedited supplementary material. Springer Berlin Heidelberg 2023-06-14 2023 /pmc/articles/PMC10390399/ /pubmed/37311879 http://dx.doi.org/10.1007/s00125-023-05949-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Hammer, Sandra S. Dorweiler, Tim F. McFarland, Delaney Adu-Agyeiwaah, Yvonne Mast, Natalia El-Darzi, Nicole Fortmann, Seth D. Nooti, Sunil Agrawal, Devendra K. Pikuleva, Irina A. Abela, George S. Grant, Maria B. Busik, Julia V. Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy |
title | Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy |
title_full | Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy |
title_fullStr | Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy |
title_full_unstemmed | Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy |
title_short | Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy |
title_sort | cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390399/ https://www.ncbi.nlm.nih.gov/pubmed/37311879 http://dx.doi.org/10.1007/s00125-023-05949-w |
work_keys_str_mv | AT hammersandras cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy AT dorweilertimf cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy AT mcfarlanddelaney cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy AT aduagyeiwaahyvonne cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy AT mastnatalia cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy AT eldarzinicole cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy AT fortmannsethd cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy AT nootisunil cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy AT agrawaldevendrak cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy AT pikulevairinaa cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy AT abelageorges cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy AT grantmariab cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy AT busikjuliav cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy |